메뉴 건너뛰기




Volumn 28, Issue 164, 2010, Pages 138-143

Chronic kidney disease related to mineral and bone disorders;Mineraine i kostne zaburzenia zwia̧zane z przewlekła̧ choroba̧ nerek

Author keywords

Bone disorders; Chronic kidney disease

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; TNFSF11 PROTEIN, HUMAN;

EID: 77949468099     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (30)
  • 1
    • 58149339930 scopus 로고    scopus 로고
    • Media calcification and intima calcification are distinct entities in chronic kidney disease
    • Amann K.: Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2008, 6, 1599-1605.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.6 , pp. 1599-1605
    • Amann, K.1
  • 2
    • 33645880441 scopus 로고    scopus 로고
    • Long-term comparison of sevelamer hydrochloride to calcium containing phosphate binders
    • Brewster U.C., Ciampi M.A., Abu-Alfa A.K.: Long-term comparison of sevelamer hydrochloride to calcium containing phosphate binders. Nephrology (Carlton), 2006, 11, 142-146.
    • (2006) Nephrology (Carlton) , vol.11 , pp. 142-146
    • Brewster, U.C.1    Ciampi, M.A.2    Abu-Alfa, A.K.3
  • 3
    • 58049213889 scopus 로고    scopus 로고
    • Location of acute coronary artery thrombses in patients with and without chronic kidney disease
    • Charytan D.M., Kuntz R.E., Garshick M.: Location of acute coronary artery thrombses in patients with and without chronic kidney disease. Kidney. Int., 2009, 75, 1, 80-87.
    • (2009) Kidney. Int , vol.75 , Issue.1 , pp. 80-87
    • Charytan, D.M.1    Kuntz, R.E.2    Garshick, M.3
  • 4
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Chertow G.M., Burke S.K., Raggi P.: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney. Int., 2002, 62, 245-252.
    • (2002) Kidney. Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 5
    • 31044455712 scopus 로고    scopus 로고
    • Paricalcitol capsule for the treatment of secondary hyperparathyroisism in stages 3 and 4 CKD
    • Coyne D.W., Acharaya M., Qin P.: Paricalcitol capsule for the treatment of secondary hyperparathyroisism in stages 3 and 4 CKD. Am. J. Kidney. Dis., 2006, 47, 263-276.
    • (2006) Am. J. Kidney. Dis , vol.47 , pp. 263-276
    • Coyne, D.W.1    Acharaya, M.2    Qin, P.3
  • 6
    • 0036895239 scopus 로고    scopus 로고
    • 3 on serum calcium and phosphorus in hemodialysis patents
    • 3 on serum calcium and phosphorus in hemodialysis patents. Am. J. Kidney. Dis., 2002, 40, 1283-1288.
    • (2002) Am. J. Kidney. Dis , vol.40 , pp. 1283-1288
    • Coyne, D.W.1    Grieff, M.2    Ahya, S.N.3
  • 7
    • 53749105878 scopus 로고    scopus 로고
    • Consistent control of mineral and bone disorder in incident hemodialysis patients
    • Denese M.D., Belozeroff V., Smirnakis K.: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol., 2008, 3(5), 1423-1429.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.3 , Issue.5 , pp. 1423-1429
    • Denese, M.D.1    Belozeroff, V.2    Smirnakis, K.3
  • 8
    • 0033624518 scopus 로고    scopus 로고
    • Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2) therapy for secondary hyperparathyroidism
    • Frazao J.M., Elangovan L., Maung H.M.: Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2) therapy for secondary hyperparathyroidism. Am. J. Kidney. Dis. 2000, 36, 3, 550-561.
    • (2000) Am. J. Kidney. Dis , vol.36 , Issue.3 , pp. 550-561
    • Frazao, J.M.1    Elangovan, L.2    Maung, H.M.3
  • 9
    • 85206956135 scopus 로고    scopus 로고
    • Giachelli C.M: The emerging role of phosphate in vascular calcification. Kidney.Int., 2009. (epub ahead of print).
    • Giachelli C.M: The emerging role of phosphate in vascular calcification. Kidney.Int., 2009. (epub ahead of print).
  • 10
    • 0034682247 scopus 로고    scopus 로고
    • Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
    • Goodman W.G., Goldin J., Kuizon B.D.: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl. J. Med., 2000, 342, 1478-1483.
    • (2000) N Engl. J. Med , vol.342 , pp. 1478-1483
    • Goodman, W.G.1    Goldin, J.2    Kuizon, B.D.3
  • 11
    • 52449118724 scopus 로고    scopus 로고
    • Long term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment
    • Hutchinson A.J., Barnett M.E., Krause R.: Long term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron. Clin. Pract., 2008, 110, c15-c23.
    • (2008) Nephron. Clin. Pract , vol.110
    • Hutchinson, A.J.1    Barnett, M.E.2    Krause, R.3
  • 12
    • 77949427864 scopus 로고    scopus 로고
    • Isakova T., Gutierrez O.M., Chang Y.: Phosphorus binders and survival on hemodialysis J. Am.Soc. Nephrol., 2008, 17, epub. ahead of print.
    • Isakova T., Gutierrez O.M., Chang Y.: Phosphorus binders and survival on hemodialysis J. Am.Soc. Nephrol., 2008, 17, epub. ahead of print.
  • 13
    • 48249147434 scopus 로고    scopus 로고
    • Treatment o chronic kidney disease-mineral and bone disorder (CKD-MBD)
    • Komaba H., Tanaka M., Fukagawa M.: Treatment o chronic kidney disease-mineral and bone disorder (CKD-MBD) Intern. Med., 2008, 989-994.
    • (2008) Intern. Med , pp. 989-994
    • Komaba, H.1    Tanaka, M.2    Fukagawa, M.3
  • 14
    • 38749153987 scopus 로고    scopus 로고
    • Battelground: Chronic kidney disorders mineral and bone disease-calcium obsession, vitamin D, and binder confusion
    • Kovesdy C.P., Mehrotra R., Kalantar-Zadeh K.: Battelground: chronic kidney disorders mineral and bone disease-calcium obsession, vitamin D, and binder confusion. Clin. J. Am. Soc. Nephrol., 2008, 3, 168-173.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.3 , pp. 168-173
    • Kovesdy, C.P.1    Mehrotra, R.2    Kalantar-Zadeh, K.3
  • 15
    • 58449107131 scopus 로고    scopus 로고
    • 3, arterial calcifications and cardiovascular risk markers in hemodialysis patients
    • 3, arterial calcifications and cardiovascular risk markers in hemodialysis patients, Nephrol. Dial. Transplant., 2009, 24, 2, 611-618.
    • (2009) Nephrol. Dial. Transplant , vol.24 , Issue.2 , pp. 611-618
    • Matias, P.J.1    Ferreira, C.2    Jorge, C.3
  • 16
    • 58149352649 scopus 로고    scopus 로고
    • Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease
    • McCullough P.A., Agrawal V., Danielewicz E.: Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin. J. Am. Soc. Nephrol., 2008, 3, 1585-1598.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.3 , pp. 1585-1598
    • McCullough, P.A.1    Agrawal, V.2    Danielewicz, E.3
  • 17
    • 38749101028 scopus 로고    scopus 로고
    • The OPTIMA study: Assessing a new cinacalcet (sensipar/mimpara) treatment algorithmfor secondary hyperparathyroidism
    • Messa P., Macario F., Yaqoob M.: The OPTIMA study: assessing a new cinacalcet (sensipar/mimpara) treatment algorithmfor secondary hyperparathyroidism. Clin. J. Am. Soc. Nephrol., 2008, 3, 36-45.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.3 , pp. 36-45
    • Messa, P.1    Macario, F.2    Yaqoob, M.3
  • 18
    • 33645757920 scopus 로고    scopus 로고
    • Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Moe S., Drfjeke T., Cunningham J.: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney. Int., 2006, 1945-1953.
    • (2006) Kidney. Int , pp. 1945-1953
    • Moe, S.1    Drfjeke, T.2    Cunningham, J.3
  • 19
    • 58149374010 scopus 로고    scopus 로고
    • Improving global outcomes in mineral and bone disorders
    • Moe S., Drüeke T.: Improving global outcomes in mineral and bone disorders. Clin. J. Am. Soc. Nephrol., 2008, 3, 127-130.
    • (2008) Clin. J. Am. Soc. Nephrol , vol.3 , pp. 127-130
    • Moe, S.1    Drüeke, T.2
  • 20
    • 34547121836 scopus 로고    scopus 로고
    • The case against calcium-based phosphate binders
    • Moe S.M., Chertow G.M.: The case against calcium-based phosphate binders. Clin J. Am. Soc. Nephrol., 2006, 1, 697-703.
    • (2006) Clin J. Am. Soc. Nephrol , vol.1 , pp. 697-703
    • Moe, S.M.1    Chertow, G.M.2
  • 21
    • 77949481605 scopus 로고    scopus 로고
    • Zalecenia Grupy Roboczej Zespohi Krajowego Konsultanta Medycznego w Dziedzinie Nefrologii dotycza̧ce rozpoznawania i leczenia zaburzeń gospodarki wapniowo-fosforanowej u pacjentów z przewleka̧ choroba̧ nerek
    • Nowicki M., Rutkowski B., Czekalski S.: Zalecenia Grupy Roboczej Zespohi Krajowego Konsultanta Medycznego w Dziedzinie Nefrologii dotycza̧ce rozpoznawania i leczenia zaburzeń gospodarki wapniowo-fosforanowej u pacjentów z przewleka̧ choroba̧ nerek. Nefrol. Dial. Pol., 2007, 11, 45-52.
    • (2007) Nefrol. Dial. Pol , vol.11 , pp. 45-52
    • Nowicki, M.1    Rutkowski, B.2    Czekalski, S.3
  • 23
    • 43849094954 scopus 로고    scopus 로고
    • A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study
    • Qunibi W., Moustafa M., Bernardo M.: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am. J. Kidney Dis., 2008, 51, 6, 1022-1023.
    • (2008) Am. J. Kidney Dis , vol.51 , Issue.6 , pp. 1022-1023
    • Qunibi, W.1    Moustafa, M.2    Bernardo, M.3
  • 24
    • 58049208295 scopus 로고    scopus 로고
    • Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
    • Rodriguez-Garcia M., Gomez-Alonso C., Naves-Diaz M. i wsp.: Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol. Dial. Transplant., 2009, 24, 1, 239-246.
    • (2009) Nephrol. Dial. Transplant , vol.24 , Issue.1 , pp. 239-246
    • Rodriguez-Garcia, M.1    Gomez-Alonso, C.2    Naves-Diaz, M.3
  • 25
    • 4043158681 scopus 로고    scopus 로고
    • Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor- κB ligand in Mönckenberg's sclerosis and atherosclerosis
    • Schoppet M., Al-Fakhiri N., Franke F.E.: Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor- κB ligand in Mönckenberg's sclerosis and atherosclerosis J. Clin. Endocrinol. Metab., 2004, 89(9), 4104-4112.
    • (2004) J. Clin. Endocrinol. Metab , vol.89 , Issue.9 , pp. 4104-4112
    • Schoppet, M.1    Al-Fakhiri, N.2    Franke, F.E.3
  • 26
    • 54949147219 scopus 로고    scopus 로고
    • Matrix Gla protein: The calcification inhibitor in need of vitamin K
    • Schurgers L.J., Cranenburg E.C., Vermeer C.: Matrix Gla protein: the calcification inhibitor in need of vitamin K. Thromb. Haemost 2008, 100, 4, 593-603.
    • (2008) Thromb. Haemost , vol.100 , Issue.4 , pp. 593-603
    • Schurgers, L.J.1    Cranenburg, E.C.2    Vermeer, C.3
  • 27
    • 33947303700 scopus 로고    scopus 로고
    • The vascular biology of calcification
    • Shroff R.C., Shanahan C.M.: The vascular biology of calcification. Semin. Dial., 2007, 2, 103-109.
    • (2007) Semin. Dial , vol.2 , pp. 103-109
    • Shroff, R.C.1    Shanahan, C.M.2
  • 28
    • 0037378444 scopus 로고    scopus 로고
    • Parikalcitol versus calcitriol therapy in the treatment of secondary hyperparathyroidism
    • Sprague S.M., Llach F., Amdahl M.: Parikalcitol versus calcitriol therapy in the treatment of secondary hyperparathyroidism. Kidney Int., 2003, 63, 1483-1490.
    • (2003) Kidney Int , vol.63 , pp. 1483-1490
    • Sprague, S.M.1    Llach, F.2    Amdahl, M.3
  • 29
    • 39449117385 scopus 로고    scopus 로고
    • A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and mortality in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
    • St Peter W.L., Liu J., Weinhandl E.: A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and mortality in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am. J. Kidney Dis., 2008, 51, 3, 445-454.
    • (2008) Am. J. Kidney Dis , vol.51 , Issue.3 , pp. 445-454
    • St Peter, W.L.1    Liu, J.2    Weinhandl, E.3
  • 30
    • 0042343804 scopus 로고    scopus 로고
    • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
    • Teng M., Wolf M., Lowrie E.: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N. Engl. J. Med., 2003, 349, 446-456.
    • (2003) N. Engl. J. Med , vol.349 , pp. 446-456
    • Teng, M.1    Wolf, M.2    Lowrie, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.